openPR Logo
Press release

Major Market Shift in Metered Dose Inhaler Devices Industry: Impact Of Rising COPD Prevalence On The Growth Of The Market

02-19-2025 06:42 AM CET | Health & Medicine

Press release from: The Business Research Company

Metered Dose Inhaler Devices Market Size

Metered Dose Inhaler Devices Market Size

What Is the Forecasted Market Size and Growth Rate for the Metered Dose Inhaler Devices Market?
The market size of metered dose inhaler devices has seen robust growth in the past few years. The market is projected to swell from $15.46 billion in 2024 to $16.36 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 5.8%. The surge in growth during the historic period can be linked to rising cases of diabetes, an amplified demand for metered dose inhaler devices, an increase in supply of these devices, along with growing cases of COPD.

In the coming years, the market size for metered dose inhaler devices is predicted to experience substantial growth, reaching $20.29 billion by 2029 with an annual compound growth rate of 5.5%. Factors contributing to growth during the forecast period include a rise in chronic obstructive pulmonary diseases, an increase in asthma cases, the prevalence of infectious diseases, a surge in diabetes cases, and rise in respiratory diseases. The forecast period is also expected to witness major trends such as technological breakthroughs, innovative treatments, regulatory approvals, the introduction of new inhalers, and the utilization of internet marketing strategies.

What Factors Are Propelling the Expansion of the Metered Dose Inhaler Devices Market?
The anticipated growth of the metered dose inhaler devices market is tied to the rising incidence of chronic obstructive pulmonary disease (COPD). This progressive lung disease, defined by airflow obstruction due to long-term irritant exposure-such as tobacco smoke-causes symptoms like coughing, shortness of breath, and wheezing. The increasing occurrence of COPD is fuelled by factors like tobacco use, air pollution, aging population, and lack of timely diagnosis or treatment. Metered dose inhaler (MDI) devices aid in the management of COPD by administering medication directly to the lungs, thereby offering immediate relief and improving airflow. The National Institutes of Health, a US-based governmental agency, projected in December 2023 that the number of COPD cases would increase from 532 million in 2030 to a total of 592 million by 2050. Consequently, this escalating prevalence of chronic obstructive pulmonary diseases is propelling the growth of the metered dose inhaler devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp

Which Businesses Are at the Forefront of Metered Dose Inhaler Devices Market Development?
Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB

Which Key Developments Are Influencing the Metered Dose Inhaler Devices Market?
Major players in the metered dose inhaler devices market are concentrating their efforts on the creation of advanced technological solutions, such as pressurized metered dose inhalers, to boost drug delivery effectiveness and foster better patient adherence. Pressurized metered-dose inhalers (pMDIs) are inhalation tools that use pressurized propellants to deliver an exact amount of medication in aerosol form. For example, in July 2023, the India-based pharmaceutical company, Lupin Limited, unveiled Luforbec 100/6, a pMDI for adult asthma and chronic obstructive pulmonary disease (COPD) treatment in Germany. This product, blending beclometasone (100 μg) and formoterol (6 μg), offers an efficient solution for patients who need combination therapy. Importantly, Luforbec is approximately 47% cheaper than the fixed reference price, improving its affordability. Given that asthma affects roughly 5% of Germany's adult population, this launch highlights Lupin's dedication to meet essential healthcare demands and enhance patient results in respiratory care.

How Is the Metered Dose Inhaler Devices Market Segmented?
The metered dose inhaler devices market covered in this report is segmented -

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types
2) By Distribution Channel: Online, Offline
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications
4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:
1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices
2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices
3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

Where Is the Metered Dose Inhaler Devices Market Growth Most Prominent?
North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Metered Dose Inhaler Devices Global Market Report?

- Market Size Analysis: Analyze the metered dose inhaler devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the metered dose inhaler devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall metered dose inhaler devices market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the metered dose inhaler devices market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20878

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Major Market Shift in Metered Dose Inhaler Devices Industry: Impact Of Rising COPD Prevalence On The Growth Of The Market here

News-ID: 3875405 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Metered

Launch Of Affordable Pressurized Metered Dose Inhaler For Asthma And COPD Treatm …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Metered Dose Inhaler Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size for metered dose inhaler devices has seen robust growth. It is predicted to rise from $15.46 billion in 2024 to $16.23 billion in 2025, registering a compound
North America Leads the Surge in Metered-Dose Inhalers Market Adoption | Metered …
The Global Metered-Dose inhalers Market reached US$ 16.6 billion in 2023 and is expected to reach US$ 24.18 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033. The Metered-Dose Inhalers (MDI) Market focuses on drug delivery devices used in managing respiratory disorders like asthma and COPD. MDIs provide precise, portable, and fast-acting medication administration. The market is expanding due to growing respiratory disease incidence and environmental
RPG Squarefoot Solutions Metered Services Plans
RPG Squarefoot Solutions Announces New Metered Services Plans for Streamlined Equipment Management and Transparent Billing [Arlington, VA- April 4, 2025] - RPG Squarefoot Solutions is proud to introduce a suite of innovative-metered service plans designed to simplify equipment usage, reduce operational burdens, and provide transparent, usage-based billing for organizations of all sizes. RPG Squarefoot Solutions Metered Services Plans Squarefoot Solutions Plan The Squarefoot Solutions Plan is a comprehensive, transparent square foot-based usage contract that
Metered Dose Inhaler Devices Market Insights, Forecast to 2031
"Metered Dose Inhaler Devices Market 2024," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Metered Dose Inhaler Devices market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Metered Dose Inhaler Devices industry, providing
Metered Dose Inhalers Market Size 2024 to 2031.
Market Overview and Report Coverage A Metered Dose Inhaler (MDI) is a device used to deliver medication into the lungs in the form of a mist. It is commonly used for the treatment of respiratory diseases such as asthma, COPD, and other respiratory conditions. The MDI market is expected to witness significant growth in the coming years. The Metered Dose Inhalers Market is projected to grow at a CAGR of
Metered Aerosol Valve Market Size 2024 to 2031.
Market Overview and Report Coverage A Metered Aerosol Valve is a device that releases a set amount of aerosol spray with each press of a button or trigger. These valves are commonly used in products such as air fresheners, personal care products, insecticides, and more. The Metered Aerosol Valve Market is expected to grow at a CAGR of 17.00% during the forecasted period. The market is driven by the increasing